Product Information
TREXALL 10 MG TABLET is a brand (anda) product labeled by Teva Women's Health, Inc., priced at $48.2096 per EA under NDC 51285036801. Its NADAC has been published 80 times since Dec 18, 2024.
The High Outlier badge above means this manufacturer's average price in the Methotrexate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Teva Women's Health, Inc.NDC
51285036801
Classification
Brand (ANDA)
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METHOTREXATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA040385On Market Since
5/3/2001
Pharmacological Classes
Price Statistics
The NADAC for TREXALL 10 MG TABLET has been published 80 times since Dec 18, 2024, and over the history we have for it it has risen 19.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $48.2096 per EA |
|---|---|
| All-time high | $48.4836 (May 13, 2026) |
| All-time low | $40.5098 (Dec 18, 2024) |
| 52-week high | $48.4836 |
| 52-week low | $44.3177 |
| Median price | $44.3177 |
| Average price | $45.4659 |
| Largest weekly change | +9.4% (Jan 7, 2026) |
| Weeks tracked | 80 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Methotrexate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TREXALL 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TREXALL 10 MG TABLET, manufactured by Teva Women's Health, Inc., is $48.2096 per EA (NDC 51285036801), effective Jun 24, 2026.
How has the price of TREXALL 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for TREXALL 10 MG TABLET has risen 19.0%. It has been tracked across 80 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for TREXALL 10 MG TABLET?
Since Dec 18, 2024, the NADAC for TREXALL 10 MG TABLET has ranged from a low of $40.5098 (Dec 18, 2024) to a high of $48.4836 (May 13, 2026), with a median of $44.3177 per EA.
Are there cheaper alternatives to TREXALL 10 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TREXALL 10 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures TREXALL 10 MG TABLET?
TREXALL 10 MG TABLET (NDC 51285036801) is labeled by Teva Women's Health, Inc., and CMS classifies it as a brand (anda) product.
Related Drugs
Same classification